戻る Agenda
ON DEMAND - Updates of Drug Evaluation and Inspection in China
Session Chair(s)
Ling Su, PHD
Research Fellow
Yeehong Business School, China
This forum will include discussions and updates from CCDIE and NMPA leadership on many important topics including the implementation of the revision of drug law and updated regulations, ICH implementation, and advanced therapy.
Learning Objective : Discuss updates from CCDIE and NMPA leadership.
Speaker(s)
New Progress of New Drug Evaluation
Fan Zhang, MS
National Medical Products Administration (NMPA), China
Project Manager, Center for Drug Evaluation (CDE)
Pre-Approval Inspection in China: Its Evolution and Key Points of Evaluation Principles
Yi Cao, MS
Center for Food and Drug Inspection (CFDI), China
Deputy Division Director, Div 4
Key Points and Evaluation Principles of Pre-Approval Inspection in China
Tiewei Zhai
Center for Food and Drug Inspection (CFDI), China
Deputy Division Director, Inspection Division 4